Clinical Trials Logo

Inflammation clinical trials

View clinical trials related to Inflammation.

Filter by:

NCT ID: NCT02777138 Active, not recruiting - Aging Clinical Trials

Impact of Ageing on Adipose, Muscle and Systemic Inflammation

Start date: May 2016
Phase:
Study type: Observational

The accumulation and dysfunction of excess adipose (fat) tissue that occurs with ageing is associated with a number of chronic inflammatory disorders such as type 2 diabetes and cardiovascular disease but the underlying mechanisms are not understood.

NCT ID: NCT02769637 Terminated - Cystic Fibrosis Clinical Trials

Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)

Start date: September 7, 2017
Phase:
Study type: Observational

Mucus in the airways of patients with CF represents an area for bacteria proliferation, microbial infection and inflammation. Similar to the lung, the esophagus provides an environment for bacterial to grow. The overall goal of this proposal is to characterize the esophageal microbiota of children with CF that are treated or untreated with acid blockade medication and to measure its possible impact on respiratory disease to develop novel treatment strategies.

NCT ID: NCT02767973 Recruiting - Allergic Asthma Clinical Trials

To Identify Persons Who Are Susceptible to WSP-induced Inflammation and Examine the Role of GSTM1 and Other Factors in This Susceptibility

SmokeScreen
Start date: May 2016
Phase: N/A
Study type: Interventional

Purpose: This screening protocol is designed to assess PMN (neutrophil) responsiveness to wood smoke particles (WSP) and the effect of the GSTM1 null genotype on this response. The researches will identify persons responsive and resistant to the inflammatory effect of WSP. It is anticipated that the GSTM1 genotype will be a risk factor for increased response to WSP.

NCT ID: NCT02764736 Withdrawn - Clinical trials for Complication of Renal Dialysis

Atorvastatin Reduces Chronic Inflammation and aVerage Epogen Dose (ARChIVED)

ARChIVED
Start date: March 4, 2016
Phase: N/A
Study type: Interventional

The specific aim of this trial is to determine whether initiating moderate- or high-intensity atorvastatin therapy in hemodialysis patient not previously on a statin reduces inflammation and lowers average Epogen utilization. Statin naive patients on maintenance HD will be started on 20mg atorvastatin daily for weeks and then titrated up to 40mg atorvastatin daily for an additional 12 weeks. Patient's inflammatory markers (ferritin, CRP) and weekly Epogen usage will be monitored.

NCT ID: NCT02764684 Completed - HIV Clinical Trials

The Effect of Probiotics on Microbial Translocation and Inflammation in HIV-infected Patients

Start date: January 2015
Phase: N/A
Study type: Interventional

Objective: In this study the investigators aim at investigating: 1. probiotics ability to modulate the microbiome and microbial translocation, 2. if probiotics affect the level of cholesterol, triglycerides as markers of cardiovascular risk factors and 3. if a reduction of microbial translocation is associated with a reduction of inflammation in the gastro-intestinal tract. Design: The study is a prospective clinical intervention trial of 40 HIV-infected patients. Method: The investigator will administer the bacteria Lactobacillus Rhamnosus in capsular form to each patient 2 times a day in 8 weeks. At baseline and at the 8th week of the intervention, the investigators will collect blood samples, feces samples and make a positron emission tomography-magnetic resonance scans.

NCT ID: NCT02764437 Completed - Allergic Asthma Clinical Trials

AsthMatic Inflammation and Neurocircuitry Activation (MINA)

MINA
Start date: July 28, 2016
Phase:
Study type: Observational

The investigators have identified areas of the brain that are activated in response to disease-related emotional information, following whole lung allergen challenge in asthma. They propose that activity in these central nervous system locations, as measured by fMRI, is associated with the intensity of allergic inflammation, provoked by segmental bronchial challenge, in the absence of significant airflow obstruction. The investigators predict that this relationship will be mediated by changes in expression of genes in the IL-1β/IL-17 pathway.

NCT ID: NCT02761096 Completed - Brain Tumor Clinical Trials

Effect of Acupuncture on Inflammation and Immune Function After Craniotomy

Start date: April 2016
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of acupuncture on inflammation and immune function after craniotomy. This study will be a single-center, parallel group clinical trial that will be conducted at Kyung Hee University Hospital at Gangdong, Seoul, Korea.

NCT ID: NCT02758795 Completed - Inflammation Clinical Trials

Antiinflammatory Effect of Dietary Protein Intake in Elderly People

AEDP
Start date: February 2016
Phase: N/A
Study type: Interventional

The aim is to evaluate the effect of ingestion of a modified bovine milk protein on circulating markers of inflammation in healthy men and women aged 50-70y.The focus is healthy ageing, i.e. delaying the deterioration in health status in older adults. Loss of lean tissue mass, termed sarcopenia is a consequence of aging per se, modified by nutrition and lifestyle behaviour. Advancing the prospect of 'successful aging' a 6-month period of protein-based nutritional support has shown preservation/accrual of lean tissue. Chronic low-grade inflammation is common in ageing and is a compounding factor leading to 'anabolic blunting', i.e. a reduced sensitivity of lean tissue to enhance the synthesis of lean tissue mass in response to protein feeding. Using a simulated human gastrointestinal digestion model we have recently shown proteins to have an anti-inflammatory bioactivity in vitro. This study investigates whether the anti-inflammatory response is retained, post-digestion in vivo.

NCT ID: NCT02752295 Completed - Inflammation Clinical Trials

Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients

ISCIW
Start date: May 2015
Phase: N/A
Study type: Interventional

This study intents to determine who will benefit from an intensive brief stress coping intervention week (ISCIW) as secondary prevention for real world affective disorder patients.

NCT ID: NCT02748655 Completed - Sports Recovery Clinical Trials

Alkaline Ionized Water: Sports Recovery and Inflammation Management

Start date: March 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether consumption of alkaline ionized water is effective for accelerating sports recovery.